Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.37B | 15.78B | 16.95B | 15.62B | 14.53B | Gross Profit |
4.51B | 4.10B | 4.28B | 5.19B | 4.97B | EBIT |
286.30M | 620.30M | 956.90M | 1.82B | 1.47B | EBITDA |
1.33B | 802.70M | 942.80M | 2.35B | 2.00B | Net Income Common Stockholders |
294.30M | -310.50M | 170.30M | 1.69B | 1.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
290.50M | 449.40M | 395.60M | 142.30M | 1.38B | Total Assets |
21.85B | 23.66B | 24.96B | 28.20B | 23.57B | Total Debt |
6.23B | 7.30B | 7.46B | 6.60B | 4.25B | Net Debt |
5.94B | 6.86B | 7.06B | 6.45B | 2.87B | Total Liabilities |
13.13B | 14.61B | 15.25B | 16.61B | 12.50B | Stockholders Equity |
8.72B | 9.06B | 9.71B | 11.59B | 11.06B |
Cash Flow | Free Cash Flow | |||
753.00M | 852.60M | -1.99B | 144.00M | 1.67B | Operating Cash Flow |
1.11B | 1.19B | -1.46B | 663.10M | 2.02B | Investing Cash Flow |
394.20M | -327.70M | 3.60B | -2.62B | -1.57B | Financing Cash Flow |
-1.56B | -816.00M | -2.00B | 914.60M | 610.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $86.08B | 27.66 | 24.08% | 1.00% | 0.41% | 19.76% | |
74 Outperform | $25.50B | 24.45 | 16.99% | 1.82% | 8.03% | 7.66% | |
65 Neutral | $147.01B | 38.89 | 7.87% | 0.53% | -13.50% | -17.25% | |
62 Neutral | $32.83B | 39.55 | 8.24% | 0.10% | 5.22% | 8.01% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% | |
60 Neutral | $1.24B | ― | -74.19% | 6.85% | -7.28% | -272.76% | |
48 Neutral | $13.36B | 45.73 | 3.38% | 3.88% | -2.63% | ― |
Stanley Black & Decker is strategizing to mitigate potential financial impacts from anticipated tariff increases under the new administration, which could significantly affect its operating income by $200 million annually. By adjusting supply chains and negotiating price increases, the company aims to reduce these costs over the next 12 to 24 months. Despite these challenges, management remains committed to its long-term growth and profitability goals, leveraging its strong U.S. manufacturing base to offset potential setbacks.
Mojdeh Poul will not seek re-election to Stanley Black & Decker’s board of directors at the 2025 annual meeting as she transitions to her new role as CEO of Integra LifeSciences Holdings. Her decision aligns with Integra’s policies on board service and is not due to any disagreements with Stanley Black & Decker.